WHO ICTRP trial

Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with…

JPRN-C000000093 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-C000000093
Public title Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
Scientific title Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III) - Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with…
Primary sponsor Japan Clinical Oncology Group(JCOG)
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase III
Countries Japan
Conditions T2-T4aN0M0 invasive bladder cancer
Interventions A:radical cystectomy alone B:neoadjuvant MVAC chemotharapy + radical cystectomy
Registration date Aug 30, 2005
Target size 360
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations